This startup develops a rapid diagnostic test platform that uses DNA/RNA-based sensors and nanoparticles to detect and quantify specific biomarkers. The platform provides highly accurate and sensitive results within minutes, eliminating the need for complex lab equipment and cold chain storage.
Funding
$149.8K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional antibody-based diagnostics face limitations in specificity, stability, and development time, hindering rapid and accurate detection of critical targets. Current diagnostic methods often require complex lab equipment and cold chain storage, increasing costs and limiting accessibility.
Solution
Hummsa Biotech offers a novel platform reagent technology, InsGen, that utilizes DNA/RNA-based nanosensors to detect and quantify specific biomarkers with high precision and speed. The InsGen kit employs DNA/RNA with nanoparticles to create DNA sensors that selectively bind to chosen targets, producing a color change that indicates the presence and quantity of the target. This technology overcomes the limitations of traditional antibodies by offering superior specificity, stability, and rapid development capabilities. The platform delivers qualitative and quantitative results in approximately one minute, eliminating the need for complex lab equipment and cold chain storage.
Target Audience
The primary target audience includes healthcare providers, diagnostic labs, and research institutions seeking rapid, accurate, and cost-effective diagnostic solutions.
Features
- DNA/RNA-based nanosensors for highly specific and accurate target detection
- Rapid results in approximately one minute, enhancing productivity
- Quantitative analysis, providing the quantity of the target present
- Cost-effective solution, offering a tenfold increase in cost-effectiveness compared to traditional methods
- Hassle-free one-step protocol that doesn't require cold chain storage
- Five times longer shelf life compared to conventional antibody tests